929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

benzydamine hydrochloride 0.3% spray, 15 mL

benzydamine hydrochloride 3 mg lozenge, 16

benzydamine hydrochloride 3 mg lozenge, 2

benzydamine hydrochloride 3% cream, 30 g

benzydamine hydrochloride 3% cream, 75 g

benzydamine hydrochloride 3% gel, 30 g

benzydamine hydrochloride 3% gel, 75 g

benzydamine hydrochloride 5% gel, 30 g

benzydamine hydrochloride 5% gel, 75 g

benzyl alcohol 12 mg + cetylpyridinium chloride 2 mg lozenge, 24

benzyl alcohol 5 mg + cetylpyridinium chloride 1.3 mg lozenge, 16 lozenges (medicinal product pack)

benzyl alcohol 5 mg + cetylpyridinium chloride 1.3 mg lozenge, 2

benzyl alcohol 6 mg + cetylpyridinium chloride 1.3 mg + eucalyptus oil 5 mg + menthol 6 mg lozenge, 16 lozenges (medicinal product pack)

benzyl alcohol 6 mg + cetylpyridinium chloride 1.3 mg lozenge, 16

benzyl alcohol 6 mg + cetylpyridinium chloride 1.3 mg lozenge, 2

zinc oxide 10.75% + peru balsam 1.88% + benzyl benzoate 1.25% ointment, 50 g

benzyl benzoate 25% lotion, 200 mL

zinc oxide 300 mg + peru balsam 50 mg + benzyl benzoate 33 mg suppository, 12

benzylpenicillin 1.2 g injection, 1 vial

benzylpenicillin 3 g injection, 1 vial

benzylpenicillin 6 g injection, 1 vial

benzylpenicillin 600 mg injection, 1 vial

beractant 200 mg/8 mL intratracheal suspension, 8 mL vial

besifloxacin 0.6% eye drops, 2 mL

besifloxacin 0.6% eye drops, 5 mL

betahistine dihydrochloride 16 mg tablet, 10

betahistine dihydrochloride 16 mg tablet, 100

betahistine dihydrochloride 16 mg tablet, 25

betahistine dihydrochloride 16 mg tablet, 30

betahistine dihydrochloride 16 mg tablet, 60

betahistine dihydrochloride 24 mg tablet, 15

betahistine dihydrochloride 24 mg tablet, 25

betahistine dihydrochloride 24 mg tablet, 60

betahistine dihydrochloride 8 mg tablet, 10

betahistine dihydrochloride 8 mg tablet, 100

betahistine dihydrochloride 8 mg tablet, 120

betahistine dihydrochloride 8 mg tablet, 25

betaine 1 g/g powder for oral liquid, 180 g

betaine 0.1% + polyaminopropyl biguanide 0.1% solution, 6 x 40 mL ampoules

betaine hydrochloride 50 mg + cellulase 5 mg + pancreatin 100 mg + papain 50 mg + tilactase 5 mg capsule, 120

betaine hydrochloride 50 mg + cellulase 5 mg + pancreatin 100 mg + papain 50 mg + tilactase 5 mg capsule, 60

betaine hydrochloride 650 mg + pepsin 31.5 mg + gentiana lutea 20 mg tablet, 90

betamethasone (as dipropionate) 470 microgram / 1 mL lotion, 30 mL (medicinal product pack)

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 2 x 60 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 60 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% gel, 30 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% gel, 60 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 100 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 120 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 15 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 3 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 30 g

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 60 g

betamethasone (as dipropionate) 0.05% cream, 15 g

betamethasone (as dipropionate) 0.05% cream, 2 g

betamethasone (as dipropionate) 0.05% cream, 30 g

betamethasone (as dipropionate) 0.05% cream, 5 g

betamethasone (as dipropionate) 0.05% cream, 50 g

betamethasone (as dipropionate) 0.05% ointment, 15 g

betamethasone (as dipropionate) 0.05% ointment, 30 g

betamethasone (as dipropionate) 0.05% ointment, 5 g

betamethasone (as dipropionate) 0.05% ointment, 50 g

betamethasone (as valerate) 0.1% cream, 100 g

betamethasone (as valerate) 0.1% cream, 2 g

betamethasone (as valerate) 0.1% cream, 30 g

betamethasone (as valerate) 1 mg / 1 g lotion, 30 g (medicinal product pack)

betamethasone (as valerate) 0.1% ointment, 2 g

betamethasone (as valerate) 0.1% ointment, 30 g

betamethasone (as valerate) 0.02% cream, 100 g

betamethasone (as valerate) 0.02% cream, 2 g

betamethasone (as valerate) 0.02% cream, 5 g

betamethasone (as valerate) 0.02% ointment, 100 g

betamethasone (as valerate) 0.05% cream, 15 g

betamethasone (as valerate) 0.05% cream, 2 g

betamethasone (as valerate) 0.05% cream, 30 g

betamethasone (as valerate) 0.05% ointment, 15 g

betamethasone (as valerate) 0.05% ointment, 2 g

betamethasone (as valerate) 0.05% ointment, 30 g

betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 2 x 1 mL ampoules

betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules

betaxolol 0.25% eye drops, 5 mL

betaxolol 0.5% eye drops, 5 mL

bethanechol chloride 10 mg tablet, 100

betiatide 1 mg injection, 5 vials

bevacizumab 100 mg/4 mL injection, 4 mL vial

bevacizumab 400 mg/16 mL injection, 16 mL vial

bezlotoxumab 1 g/40 mL injection, 40 mL vial

bicalutamide 150 mg tablet, 28

goserelin 10.8 mg implant [1 implant] (&) bicalutamide 50 mg tablet [28], 1 pack

goserelin 3.6 mg implant [1] (&) bicalutamide 50 mg tablet [28], 1 pack

leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack

leuprorelin acetate 7.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack

goserelin 10.8 mg implant [1 implant] (&) bicalutamide 50 mg tablet [84], 1 pack

leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack

bicalutamide 50 mg tablet, 10

bicalutamide 50 mg tablet, 100

bicalutamide 50 mg tablet, 28 tablets (medicinal product pack)

bicalutamide 50 mg tablet, 30

bicalutamide 50 mg tablet, 40

bicalutamide 50 mg tablet, 500

bicalutamide 50 mg tablet, 56

Start Previous Page 26 of 160 Next End

Reference Sets

Reference set descriptor